- Home
- BARK vs ORMP Comparison
BARK vs ORMP Comparison
Compare BARK & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BARK | ORMP |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.2M | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BARK | ORMP |
|---|---|---|
| Price | $0.57 | $2.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 847.4K | 163.0K |
| Earning Date | 02-04-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $451,690,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.02 | N/A |
| P/E Ratio | ★ N/A | $2.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.55 | $1.82 |
| 52 Week High | $2.32 | $3.24 |
Technical Indicators
Market Signals| Indicator | BARK | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 35.27 | 53.32 |
| Support Level | $0.55 | $2.75 |
| Resistance Level | $0.66 | $3.24 |
| Average True Range (ATR) | 0.04 | 0.15 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 18.47 | 29.48 |
Price Performance
Historical ComparisonAbout BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.